Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders

Author： Leonard Sarah Dwyer Jason Sukoff Rizzo Stacey Platt Brian Logue Sheree Neal Sarah Malberg Jessica Beyer Chad Schechter Lee Rosenzweig-Lipson Sharon Ring Robert

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.197, Iss.4, 2008-05, pp. : 601-611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

By Holmes A. Heilig M. Rupniak N.M.J. Steckler T. Griebel G.

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 580-588

Elsevier

Access to resources Recommend Favorite

Central functions of neuropeptide Y in mood and anxiety disorders

By Wu Gang Feder Adriana Wegener Gregers Bailey Christopher Saxena Shireen Charney Dennis Mathé Aleksander A

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. : 1317-1331

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptides as Therapeutic Targets in Anxiety Disorders

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5709-5727

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Kava in the Treatment of Anxiety Disorders

By Singh Y.N.

CNS Drugs, Vol. 16, Iss. 11, 2002-01 ,pp. : 731-743

Adis International

Access to resources Recommend Favorite

Quinapril: A Further Update of its Pharmacology and Therapeutic Use in Cardiovascular Disorders

By Culy C.R. Jarvis B.

Drugs, Vol. 62, Iss. 2, 2002-01 ,pp. : 339-385

Adis International

Access to resources Recommend Favorite